Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy based on the revolutionary gene-editing technology and ushering in a new phase of genetic medicine.
Comments
( ゚Д゚)
There's nothing here…